Researcher.Life Logo

Pharmacogenetics and Genomics : Impact Factor & More

eISSN: 1744-6880pISSN: 1744-6872

Key Metrics

CiteScore
4.5
Impact Factor
< 5
SJR
Q2Genetics
SNIP
0.65
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Pharmacogenetics and Genomics

Pharmacogenetics and Genomics Journal Specifications

Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2005
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Pharmacogenetics and Genomics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Pharmacogenetics and Genomics

TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel disease
  • 13 Apr 2026
  • Pharmacogenetics and Genomics
Characteristics of initial pharmacogenetic testing and subsequent physician referral behavior in youth mental health
  • 7 Apr 2026
  • Pharmacogenetics and Genomics
CFTR genotype-phenotype associations and clinical outcomes in pediatric cystic fibrosis.
  • 7 Apr 2026
  • Pharmacogenetics and genomics
NFIB rs28379954 does not affect CYP2D6-mediated metabolism of prototypical substrates, tamoxifen or solanidine.
  • 24 Mar 2026
  • Pharmacogenetics and genomics
Association of Genetic Variation in CES, UGT, ABC, and SLCO with Irinotecan Infusion Reactions and Severe Toxicity: Erratum
  • 24 Mar 2026
  • Pharmacogenetics and Genomics
The potential effect and pathway of valsartan: genome-wide and phenome-wide association study from UK Biobank data.
  • 20 Mar 2026
  • Pharmacogenetics and genomics
TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel disease
  • 13 Apr 2026
  • Pharmacogenetics and Genomics
Characteristics of initial pharmacogenetic testing and subsequent physician referral behavior in youth mental health
  • 7 Apr 2026
  • Pharmacogenetics and Genomics
CFTR genotype-phenotype associations and clinical outcomes in pediatric cystic fibrosis.
  • 7 Apr 2026
  • Pharmacogenetics and genomics
NFIB rs28379954 does not affect CYP2D6-mediated metabolism of prototypical substrates, tamoxifen or solanidine.
  • 24 Mar 2026
  • Pharmacogenetics and genomics
Association of Genetic Variation in CES, UGT, ABC, and SLCO with Irinotecan Infusion Reactions and Severe Toxicity: Erratum
  • 24 Mar 2026
  • Pharmacogenetics and Genomics
The potential effect and pathway of valsartan: genome-wide and phenome-wide association study from UK Biobank data.
  • 20 Mar 2026
  • Pharmacogenetics and genomics

FAQs on Pharmacogenetics and Genomics